Anti-JC virus (JCV) antibody index differentiates risk of progressive multifocal leukoencephalopathy in natalizumab-treated multiple sclerosis patients with no prior immunosuppressant use: an updated analysis - Kuesters, G; Plavina, T; Lee, S
Poster presented at: 67th American Academy of Neurology Annual Meeting; April 18–15, 2015; Washington, DC